1 |
Youns MM, Abdel Wahab AH, Hassan ZA, et al (2013). Serum talin-1 is a potential novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Asian Pac J Cancer Prev, 14, 3819-23.
DOI
ScienceOn
|
2 |
Zavaglia C, De Carlis L, Alberti AB, et al (2005). Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol, 100, 2708-16.
DOI
ScienceOn
|
3 |
Tian J, Tang ZY, Ye SL, et al (1999). New human hepatocellular carcinoma(HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis. Br J Cancer, 81, 814-21.
DOI
ScienceOn
|
4 |
Wang Z, Ruan YB, Guan Y, et al (2003). Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis. World J Gastroenterol, 9, 267-70.
|
5 |
Zender L, Spector MS, Xue W, et al (2006). Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell, 125, 1253-67.
DOI
ScienceOn
|
6 |
Zhang X, Jiang G, Cai Y, et al (2008). Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nat Cell Biol, 10, 1062-8.
DOI
ScienceOn
|
7 |
Zhang JL, Qian YB, Xiong QR, et al (2011). Talin1, a valuable marker for diagnosis and prognostic assessment of human hepatocelluar carcinomas. Asian Pac J Cancer Prev, 12, 3265-9.
|
8 |
Sakamoto S, McCann RO, Kyprianou N, et al (2010). Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res, 70, 1885-95.
DOI
|
9 |
Senetar MA, McCann RO (2005). Gene duplication and functional divergence during evolution of the cytoskeletal linker protein talin. Gene, 362, 141-52.
DOI
ScienceOn
|
10 |
Senetar MA, Moncman CL, McCann RO (2007). Talin2 is induced during striated muscle differentiation and is targeted to stable adhesion complexes in mature muscle. Cell Motil Cytoskeleton, 64, 157-73
DOI
ScienceOn
|
11 |
Slater M, Cooper M, Murphy CR (2007). The cytoskeletal proteins alpha-actinin, Ezrin, and talin are de-expressed in endometriosis and endometrioid carcinoma compared with normal uterine epithelium. Appl Immunohistochem Mol Morphol, 15, 170-4.
DOI
ScienceOn
|
12 |
Shafizadeh N, Kakar S (2013). Hepatocellular carcinoma: Histologic subtypes. Surgical Pathology Clinics, 6, 367-84.
DOI
|
13 |
Singel SM, Cornelius C, Batten K, et al (2013). A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer. Clin Cancer Res, 19, 2061-70
DOI
ScienceOn
|
14 |
Sriputtha S, Khuntikeo N, Promthet S, et al (2013). Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev, 14, 1107-10.
DOI
ScienceOn
|
15 |
Takayama T, Makuuchi M, Hirohashi S, et al (1990). Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet, 336, 1150-3.
DOI
ScienceOn
|
16 |
Takayama T, Makuuchi M, Hirohashi S, et al (1998). Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology, 28, 1241-6.
DOI
|
17 |
Lai MT, Hua CH, Tsai MH, et al (2011). Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis. J Pathol, 224, 367-76
DOI
ScienceOn
|
18 |
Li MS, Li PF, He SP, et al (2002). The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel-7402 cell line. World J Gastroenterol, 8, 469-75.
|
19 |
Laurent-Puig P, Zucman-Rossi J (2006). Genetics of hepatocellular tumors. Oncogene, 25, 3778-86.
DOI
ScienceOn
|
20 |
Lou CY, Feng YM, Qian AR, et al (2004). Establishment and characterization of a human hepatocellular carcinoma cell line FHCC-98. World J Gastroenterol, 10, 1462-5.
|
21 |
Morris KM, Aden DP, Knowles BB, et al (1982). Complement biosynthesis by the human hepatoma-derived cell line HePG2. J Clin Invest, 70, 906-13.
DOI
|
22 |
Monkley SJ, Pritchard CA, Critchley DR (2001). Analysis of the mammalian talin2 gene TLN2. Biochem Biophys Res Commun, 286, 880-5.
DOI
ScienceOn
|
23 |
Monkley SJ, Kostourou V, Spence L, et al (2011). Endothelial cell talin1 is essential for embryonic angiogenesis. Dev Biol, 349, 494-502.
DOI
ScienceOn
|
24 |
Praekelt U, Kopp PM, Rehm K, et al (2012). New isoformspecific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2. Eur J Cell Biol, 91, 180-91
DOI
ScienceOn
|
25 |
Roayaie S, Schwartz JD, Sung MW, et al (2004). Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis. Liver Transpl, 10, 534-40.
DOI
ScienceOn
|
26 |
Schafer DF, Sorrell MF (1999). Hepatocellular carcinoma. Lancet, 353, 1253-7.
DOI
ScienceOn
|
27 |
Song ZQ, Hao F, Min F, et al (2001). Hepatitis C virus infection of human hepatoma cell line 7721 in vitro. World J Gastroenterol, 7, 685-9.
|
28 |
Kopp PM, Bate N, Hansen TM, et al (2010). Studies on the morphology and spreading of human endothelial cells define key inter- and intramolecular interactions for talin1. Eur J Cell Biol, 89, 661-73
DOI
ScienceOn
|
29 |
Kakar S, Burgart LJ, Batts KP, et al (2005). Clinicopathologic features and survival in fibrolamellar carcinoma: Comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol, 18, 1417-23.
DOI
ScienceOn
|
30 |
International Consensus Group for Hepatocellular Neoplasia(2009). Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia. Hepatology, 49, 658-64.
DOI
ScienceOn
|
31 |
Kirk GD, Bah E, Montesano R (2006). Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa. Carcinogenesis, 27, 2070-82
DOI
ScienceOn
|
32 |
Kanamori H, Kawakami T, Effendi K, et al (2011). Identification by differential tissue proteome analysis of Talin-1 as a novel molecular marker of progression of hepatocellular carcinoma. Oncology, 80, 406-15
DOI
ScienceOn
|
33 |
Lack EE, Neave C, Vawter GF (1983). Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer, 52, 1510-5
DOI
|
34 |
Lauwers GY, Terris B, Balis UJ, et al (2002). International Cooperative Study Group on Hepatocellular Carcinoma. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: A multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol, 26, 25-34.
DOI
ScienceOn
|
35 |
Li Y, Tang ZY, Ye SL, et al (2001). Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol, 7, 630-6.
|
36 |
Debrand E, Conti FJ, Bate N, et al (2012). Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. Biochem Bioph Res Co, 426, 190-5
DOI
ScienceOn
|
37 |
El-Serag HB, Rudolph KL (2007). Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-76
DOI
ScienceOn
|
38 |
Conti FJ, Felder A, Monkley S, et al (2008). Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle. Development, 135, 2043-53
DOI
ScienceOn
|
39 |
Conti FJ, Monkley SJ, Wood MR, et al (2009). Talin 1 and 2 are required for myoblast fusion, sarcomere assembly and the maintenance of myotendinous junctions. Development, 136, 3597-606
DOI
ScienceOn
|
40 |
Debrand E, El Jai Y, Spence L, et al (2009). Talin 2 is a large and complex gene encoding multiple transcripts and protein isoforms. FEBS J, 276, 1610-28
DOI
ScienceOn
|
41 |
Farazi PA, DePinho RA (2006). Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer, 6, 674-87
DOI
ScienceOn
|
42 |
Fornaro M, Manes T, Languino LR (2001). Integrins and prostate cancer metastases. Cancer Metastasis Rev, 20, 321-31
DOI
ScienceOn
|
43 |
Giancotti FG, Ruoslahti E (1999). Integrin signaling. Science, 285, 1028-32
DOI
ScienceOn
|
44 |
Hodgson HJ (1987). Fibrolamellar cancer of the liver. J Hepatol, 5, 241-7
DOI
ScienceOn
|
45 |
Hui KM (2009). Human hepatocellular carcinoma: Expression profiles-based molecular interpretations and clinical applications. Cancer Lett, 286, 96-102
DOI
ScienceOn
|
46 |
Ishak KG, Goodman ZD, Stocker JT (2001). Tumors of the liver and intrahepatic bile ducts. Washington, DC: Armed Forces Institute of Pathology
|
47 |
Anthis NJ, Wegener KL, Critchley DR, et al (2010). Structural diversity in integrin/talin interactions. Structure, 18, 1654-66.
DOI
ScienceOn
|
48 |
Calderwood DA (2004). Integrin activation. J Cell Sci, 117, 657-66.
DOI
ScienceOn
|
49 |
Beer DG, Kardia SL, Huang CC, et al (2002). Geneexpression profiles predict survival of patients with lung adenocarcinoma. Nat Med, 8, 816-24.
|
50 |
Craig JR, Peters RL, Edmondson HA, et al (1980). Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer, 46, 372-9.
DOI
|
51 |
Critchley DR (2004). Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. Biochem Soc Trans, 32, 831-6
DOI
ScienceOn
|
52 |
Fazeli Z, Pourhoseingholi MA, Vahedi M, et al (2012). Burden of hepatocellular carcinoma in Asia. Asian Pac J Cancer Prev, 13, 5955-8.
DOI
ScienceOn
|